Bibliometric Analysis of Artificial Intelligence in Diabetic Retinopathy

doi:10.12114/j.issn.1007-9572.2022.0851

Abstract

Abstract:

Background

In recent years, artificial intelligence (AI) has shown rapid development in the medical field, and its application in diabetic retinopathy (DR) has been expanding.

Objective

To summarize the application of AI in DR through bibliometric analysis and elucidate the current status, hot spots and emerging trends of AI-related research in DR, with a view to providing ideas for future research.

Methods

The research was performed on the Web of Science database for the researches related to AI applications in DR from inception to 2022-11-04 and used CiteSpace software to conduct bibliometric analysis of the number of articles, countries, institutions, authors, co-citation and keywords in the literature.

Results

A total of 1 770 papers were obtained, with an overall increasing trend in the number of publications and a peak of 402 papers in 2021. China was the top country in terms of the number of publications (440), and the UK was the country with the highest intermediary centrality (0.26). A total of 436 institutions were included in the institutional collaboration network mapping, represented by Sun Yat-sen University and Capital Medical University. A total of 601 authors were included in the author collaboration network mapping, represented by JIA Y L and HWANG T. Three highly cited authors, GULSHAN V, ABRàMOFF M D and TING D W, have made important contributions to the field. Ophthalmology, Invest Ophth Vis Sci and Ieee T Med Imaging are the three most influential journals in the field of AI applied to DR. The research hot spots were mainly focused on lesion segmentation and DR diagnosis. The future research trends may be efficacy prediction of diabetic macular edema as a complication of DR, disease management and improvement of AI algorithm performance.

Conclusion

Researchers can refer to the research hot spots and trends shown by this bibliometric analysis, focusing on AI in DR diagnosis, disease management and improvement of AI algorithm performance.

Key words: Diabetic retinopathy, Artificial intelligence, CiteSpace, Bibliometric analysis, Visualization

摘要：

背景

近年来，人工智能（AI）在医学领域发展迅速，在糖尿病视网膜病变（DR）中的应用范围不断扩展。

目的

通过文献计量分析总结AI在DR领域的应用情况，阐明AI在DR领域相关研究的现状、热点和新兴趋势，以期为未来的研究提供思路。

方法

以Web of Science数据库为来源，检索建库至2022-11-04的AI应用于DR领域的相关文献，运用CiteSpace软件对纳入文献进行发文量、国家、机构、作者、共被引和关键词的文献计量学分析。

结果

共获得1 770篇文献，2011年1月至2022年11月发文量总体呈上升趋势，2021年发文量达峰值（402篇）。中国是发文量（440篇）位居第1的国家，英国为中心性（0.26）最高的国家。机构合作网络图谱共纳入436家机构，以中山大学和首都医科大学为代表。作者合作网络图谱共纳入601位作者，以JIA Y L和HWANG T为代表。GULSHAN V、ABRàMOFF M D与TING D W 3位高被引作者对该领域做出了重要贡献。Ophthalmology、Invest Ophth Vis Sci和Ieee T Med Imaging是AI应用于DR领域的相关研究最具影响力的3大期刊。AI应用于DR研究的热点领域主要集中在病灶分割和DR诊断方面。对DR并发症糖尿病性黄斑水肿的疗效预测、DR病程管理以及AI算法性能提高可能是未来的研究趋势。

结论

研究者可参考本研究所示的研究热点及趋势，重点关注AI在DR诊断、病程管理与AI算法性能提高方面的相关问题。

关键词: 糖尿病视网膜病变, 人工智能, CiteSpace, 文献计量分析, 可视化

LIU Chun,JIAN Wenyuan,DUAN Junguo. Bibliometric Analysis of Artificial Intelligence in Diabetic Retinopathy[J]. Chinese General Practice, 2023, 26(15): 1847-1856. DOI: 10.12114/j.issn.1007-9572.2022.0851.
刘春,蹇文渊,段俊国. 人工智能应用于糖尿病视网膜病变的文献计量学分析[J]. 中国全科医学, 2023, 26(15): 1847-1856. DOI: 10.12114/j.issn.1007-9572.2022.0851.

Figures/Tables 11

References 60

[1]	TING D S W，CHEUNG G C M，WONG T Y. Diabetic retinopathy: global prevalence，major risk factors，screening practices and public health challenges: a review[J]. Clin Exp Ophthalmol，2016，44（4）：260-277. DOI：10.1111/ceo.12696.
[2]	CHO N H，SHAW J E，KARURANGA S，et al. IDF Diabetes Atlas：global estimates of diabetes prevalence for 2017 and projections for 2045[J]. Diabetes Res Clin Pract，2018（138）：271-281. DOI：10.1016/j.diabres.2018.02.023.
[3]	LIEW G，MICHAELIDES M，BUNCE C. A comparison of the causes of blindness certifications in England and Wales in working age adults （16-64 years），1999-2000 with 2009-2010[J]. BMJ Open，2014，4（2）：e004015. DOI：10.1136/bmjopen-2013-004015.
[4]	BURTON M J，RAMKE J，MARQUES A P，et al. The lancet global health commission on global eye health: vision beyond 2020[J]. Lancet Glob Health，2021，9（4）：e489-551. DOI：10.1016/S2214-109X(20)30488-5.
[5]	TING D S W，PASQUALE L R，PENG L，et al. Artificial intelligence and deep learning in ophthalmology[J]. Br J Ophthalmol，2019，103（2）：167-175. DOI：10.1136/bjophthalmol-2018-313173.
[6]	DUTT S，SIVARAMAN A，SAVOY F，et al. Insights into the growing popularity of artificial intelligence in ophthalmology[J]. Indian J Ophthalmol，2020，68（7）：1339-1346. DOI：10.4103/ijo.IJO_1754_19.
[7]	张明，周思睿. 把握挑战和机遇：人工智能与眼科诊疗[J]. 中华眼底病杂志，2021，37（2）：93-97. DOI：10.3760/cma.j.cn511434-20210121-00044.
[8]	陈悦，陈超美，刘则渊，等. CiteSpace知识图谱的方法论功能[J]. 科学学研究，2015，33（2）：242-253. DOI：10.16192/j.cnki.1003-2053.2015.02.009.
[9]	CHEN C M，SONG M. Visualizing a field of research：a methodology of systematic scientometric reviews[J]. PLoS One，2019，14（10）：e0223994. DOI：10.1371/journal.pone.0223994.
[10]	李科科，于文兵，李硕奇，等. 基于CiteSpace的大学生社交焦虑研究的热点与前沿趋势分析[J]. 中国全科医学，2022，25（33）：4217-4226. DOI：10.12114/j.issn.1007-9572.2022.0390.
[11]	陈冉，杨皓然，史会连，等. 1991—2021年肝硬化营养研究热点及趋势可视化分析[J]. 中国全科医学，2022（32）：4091-4098. DOI：10.12114/j.issn.1007-9572.2022.0247.
[12]	SMALL H. Co-citation in the scientific literature：a new measure of the relationship between two documents[J]. J Am Soc Inf Sci，1973，24（4）：265-269. DOI：10.1002/asi.4630240406.
[13]	MARSHAKOVA S I. System of document connections based on references[J]. Nauch-Techn.Inform，1973，2（6）：3-8.
[14]	郝嘉树. 基于关键词聚类的领域本体层次关系半自动构建研究[J]. 情报科学，2016，34（4）：59-61，79. DOI：10.13833/j.cnki.is.2016.04.013.
[15]	GULSHAN V，PENG L，CORAM M，et al. Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs[J]. JAMA，2016，316（22）：2402-2410. DOI：10.1001/jama.2016.17216.
[16]	TING D S W，CHEUNG C Y，LIM G，et al. Development and validation of a deep learning system for diabetic retinopathy and related eye diseases using retinal images from multiethnic populations with diabetes[J]. JAMA，2017，318（22）：2211-2223. DOI：10.1001/jama.2017.18152.
[17]	GARGEYA R，LENG T. Automated identification of diabetic retinopathy using deep learning[J]. Ophthalmology，2017，124（7）：962-969. DOI：10.1016/j.ophtha.2017.02.008.
[18]	ABRÀMOFF M D，LOU Y Y，ERGINAY A，et al. Improved automated detection of diabetic retinopathy on a publicly available dataset through integration of deep learning[J]. Invest Ophthalmol Vis Sci，2016，57（13）：5200-5206. DOI：10.1167/iovs.16-19964.
[19]	ABRÀMOFF M D，LAVIN P T，BIRCH M，et al. Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices[J]. NPJ Digit Med，2018，1：39. DOI：10.1038/s41746-018-0040-6.
[20]	LECUN Y，BENGIO Y，HINTON G. Deep learning[J]. Nature，2015，521（7553）：436-444. DOI：10.1038/nature14539.
[21]	KERMANY D S，GOLDBAUM M，CAI W J，et al. Identifying medical diagnoses and treatable diseases by image-based deep learning[J]. Cell，2018，172（5）：1122-1131.e9. DOI：10.1016/j.cell.2018.02.010.
[22]	POPLIN R，VARADARAJAN A V，BLUMER K，et al. Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning[J]. Nat Biomed Eng，2018，2（3）：158-164. DOI：10.1038/s41551-018-0195-0.
[23]	FAUW D J，LEDSAM J R，ROMERA-PAREDES B，et al. Clinically applicable deep learning for diagnosis and referral in retinal disease[J]. Nat Med，2018，24（9）：1342-1350. DOI：10.1038/s41591-018-0107-6.
[24]	KRAUSE J，GULSHAN V，RAHIMY E，et al. Grader variability and the importance of reference standards for evaluating machine learning models for diabetic retinopathy[J]. Ophthalmology，2018，125（8）：1264-1272. DOI：10.1016/j.ophtha.2018.01.034.
[25]	LIU S，SUN Y P，GAO X L，et al. Knowledge domain and emerging trends in Alzheimer's disease：a scientometric review based on CiteSpace analysis[J]. Neural Regen Res，2019，14（9）：1643-1650. DOI：10.4103/1673-5374.255995.
[26]	YAO L M，HUI L，YANG Z，et al. Freshwater microplastics pollution：detecting and visualizing emerging trends based on Citespace II[J]. Chemosphere，2020，245：125627. DOI：10.1016/j.chemosphere.2019.125627.
[27]	尹义龙，袭肖明. 眼科疾病智能诊断方法最新进展[J]. 山东大学学报（医学版），2020，58（11）：33-38. DOI：10.6040/j.issn.1671-7554.0.2020.1136.
[28]	WANG Y L，YANG J Y，YANG J Y，et al. Progress of artificial intelligence in diabetic retinopathy screening[J]. Diabetes Metab Res Rev，2021，37（5）：e3414. DOI：10.1002/dmrr.3414.
[29]	GOUTAM B，HASHMI M F，GEEM Z W，et al. A comprehensive review of deep learning strategies in retinal disease diagnosis using fundus images[J]. IEEE Access，2022，10：57796-57823. DOI：10.1109/ACCESS.2022.3178372.
[30]	XIA H Y，LAN Y，SONG S X，et al. A multi-scale segmentation-to-classification network for tiny microaneurysm detection in fundus images[J]. Knowl Based Syst，2021，226：107140. DOI：10.1016/j.knosys.2021.107140.
[31]	LIAO Y H，XIA H Y，SONG S X，et al. Microaneurysm detection in fundus images based on a novel end-to-end convolutional neural network[J]. Biocybern Biomed Eng，2021，41（2）：589-604. DOI：10.1016/j.bbe.2021.04.005.
[32]	ZHANG X P，WU J G，MENG M，et al. Feature-transfer network and local background suppression for microaneurysm detection[J]. Mach Vis Appl，2020，32（1）：1-13. DOI：10.1007/s00138-020-01119-9.
[33]	HUANG C X，ZONG Y S，DING Y M，et al. A new deep learning approach for the retinal hard exudates detection based on superpixel multi-feature extraction and patch-based CNN[J]. Neurocomputing，2021，452：521-533. DOI：10.1016/j.neucom.2020.07.145.
[34]	KURILOVÁ V，GOGA J，ORAVEC M，et al. Support vector machine and deep-learning object detection for localisation of hard exudates[J]. Sci Rep，2021，11（1）：16045. DOI：10.1038/s41598-021-95519-0.
[35]	MOHAN N J，MURUGAN R，GOEL T，et al. Fast and robust exudate detection in retinal fundus images using extreme learning machine autoencoders and modified KAZE features[J]. J Digit Imaging，2022，35（3）：496-513. DOI：10.1007/s10278-022-00587-x.
[36]	TIAN C，FANG T，FAN Y L，et al. Multi-path convolutional neural network in fundus segmentation of blood vessels[J]. Biocybern Biomed Eng，2020，40（2）：583-595. DOI：10.1016/j.bbe.2020.01.011.
[37]	ATLI I，GEDIK O S. Sine-Net：a fully convolutional deep learning architecture for retinal blood vessel segmentation[J]. Eng Sci Technol Int J，2021，24（2）：271-283. DOI：10.1016/j.jestch.2020.07.008.
[38]	GEGUNDEZ-ARIAS M E，MARIN-SANTOS D，PEREZ-BORRERO I，et al. A new deep learning method for blood vessel segmentation in retinal images based on convolutional kernels and modified U-Net model[J]. Comput Methods Programs Biomed，2021，205：106081. DOI：10.1016/j.cmpb.2021.106081.
[39]	MAQSOOD S，DAMAŠEVI IUS R，MASKELINAS R. Hemorrhage detection based on 3D CNN deep learning framework and feature fusion for evaluating retinal abnormality in diabetic patients[J]. Sensors （Basel），2021，21（11）：3865. DOI：10.3390/s21113865.
[40]	LAHMIRI S. Hybrid deep learning convolutional neural networks and optimal nonlinear support vector machine to detect presence of hemorrhage in Retina[J]. Biomed Signal Process Control，2020，60：101978. DOI：10.1016/j.bspc.2020.101978.
[41]	BHASKARANAND M，RAMACHANDRA C，BHAT S，et al. The value of automated diabetic retinopathy screening with the EyeArt system: a study of more than 100，000 consecutive encounters from people with diabetes[J]. Diabetes Technol Ther，2019，21（11）：635-643. DOI：10.1089/dia.2019.0164.
[42]	WONG T Y，SUN J，KAWASAKI R，et al. Guidelines on diabetic eye care: the international council of ophthalmology recommendations for screening，follow-up，referral，and treatment based on resource settings[J]. Ophthalmology，2018，125（10）：1608-1622. DOI：10.1016/j.ophtha.2018.04.007.
[43]	LI F，WANG Y G，XU T Y，et al. Deep learning-based automated detection for diabetic retinopathy and diabetic macular oedema in retinal fundus photographs[J]. Eye （Lond），2022，36（7）：1433-1441. DOI：10.1038/s41433-021-01552-8.
[44]	KAUSHIK H，SINGH D，KAUR M，et al. Diabetic retinopathy diagnosis from fundus images using stacked generalization of deep models[J]. IEEE Access，9：108276-108292. DOI：10.1109/ACCESS.2021.3101142.
[45]	WANG X F，XU M，ZHANG J C，et al. Joint learning of multi-level tasks for diabetic retinopathy grading on low-resolution fundus images[J]. IEEE J Biomed Health Inform，2022，26（5）：2216-2227. DOI：10.1109/JBHI.2021.3119519.
[46]	SHANKAR K，SAIT A R W，GUPTA D，et al. Automated detection and classification of fundus diabetic retinopathy images using synergic deep learning model[J]. Pattern Recognit Lett，2020，133：210-216. DOI：10.1016/j.patrec.2020.02.026.
[47]	VAN DER HEIJDEN A A，ABRAMOFF M D，VERBRAAK F，et al. Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System[J]. Acta Ophthalmol，2018，96（1）：63-68. DOI：10.1111/aos.13613.
[48]	RAJALAKSHMI R，SUBASHINI R，ANJANA R M，et al. Automated diabetic retinopathy detection in smartphone-based fundus photography using artificial intelligence[J]. Eye（Lond），2018，32（6）：1138-1144. DOI：10.1038/s41433-018-0064-9.
[49]	ROY R，LOBO A，PAL B P，et al. Automated diabetic retinopathy imaging in Indian eyes：a pilot study[J]. Indian J Ophthalmol，2014，62（12）：1121-1124. DOI：10.4103/0301-4738.149129.
[50]	药品监督管理局，国家药监局关于批准注册96个医疗器械产品公告[EB/OL]. （2020-09-16）[2023-01-08].
[51]	TAN G S，CHEUNG N，SIMÓ R，et al. Diabetic macular oedema[J]. Lancet Diabetes Endocrinol，2017，5（2）：143-155. DOI：10.1016/S2213-8587(16)30052-3.
[52]	ALLINGHAM M J，MUKHERJEE D，LALLY E B，et al. A quantitative approach to predict differential effects of anti-VEGF treatment on diffuse and focal leakage in patients with diabetic macular edema：a pilot study[J]. Transl Vis Sci Technol，2017，6（2）：7. DOI：10.1167/tvst.6.2.7.
[53]	RASTI R，ALLINGHAM M J，METTU P S，et al. Deep learning-based single-shot prediction of differential effects of anti-VEGF treatment in patients with diabetic macular edema[J]. Biomed Opt Express，2020，11（2）：1139-1152. DOI：10.1364/BOE.379150.
[54]	ESTIL S，STEINARSSON A Þ，EINARSSON S，et al. Diabetic eye screening with variable screening intervals based on individual risk factors is safe and effective in ophthalmic practice[J]. Acta Ophthalmol，2020，98（4）：343-346. DOI：10.1111/aos.14425.
[55]	BORA A，BALASUBRAMANIAN S，BABENKO B，et al. Predicting the risk of developing diabetic retinopathy using deep learning[J]. Lancet Digit Health，2021，3（1）：e10-19. DOI：10.1016/S2589-7500(20)30250-8.
[56]	XIE Q W，LIU Y F，HUANG H，et al. An innovative method for screening and evaluating the degree of diabetic retinopathy and drug treatment based on artificial intelligence algorithms[J]. Pharmacol Res，2020，159：104986. DOI：10.1016/j.phrs.2020.104986.
[57]	TOROK Z，PETO T，CSOSZ E，et al. Combined methods for diabetic retinopathy screening，using Retina photographs and tear fluid proteomics biomarkers[J]. J Diabetes Res，2015：623619. DOI：10.1155/2015/623619.
[58]	XIE Y C，NGUYEN Q D，HAMZAH H，et al. Artificial intelligence for teleophthalmology-based diabetic retinopathy screening in a national programme：an economic analysis modelling study[J]. Lancet Digit Health，2020，2（5）：e240-249. DOI：10.1016/S2589-7500(20)30060-1.
[59]	AHUJA A S，HALPERIN L S. Understanding the advent of artificial intelligence in ophthalmology[J]. J Curr Ophthalmol，2019，31（2）：115-117. DOI：10.1016/j.joco.2019.05.001.
[60]	ZHAO M W，JIANG Y Z. Great expectations and challenges of artificial intelligence in the screening of diabetic retinopathy[J]. Eye （Lond），2020，34（3）：418-419. DOI：10.1038/s41433-019-0629-2.

序号	被引作者	被引频次（次）	中介中心性
1	GULSHAN V	412	0.03
2	ABRÀMOFF M D	363	0.17
3	TING D W	285	0.04
4	NIEMEIJER M	240	0.02
5	HE K	201	0.04
6	QUELLEC G	179	0.04
7	GARGEYA R	176	0.02
8	SZEGEDY C	172	0.03
9	DECENCIERE E	164	0.04
10	KRIZHEVSKY A	153	0.03

序号	被引作者	被引频次（次）	中介中心性
1	GULSHAN V	412	0.03
2	ABRÀMOFF M D	363	0.17
3	TING D W	285	0.04
4	NIEMEIJER M	240	0.02
5	HE K	201	0.04
6	QUELLEC G	179	0.04
7	GARGEYA R	176	0.02
8	SZEGEDY C	172	0.03
9	DECENCIERE E	164	0.04
10	KRIZHEVSKY A	153	0.03

序号	被引期刊	JCR分区	IF	被引频次	中介中心性
1	Ophthalmology	Q1	14.28	791	0.02
2	Invest Ophth Vis Sci	Q1	4.93	711	0.01
3	Ieee T Med Imaging	Q1	11.04	628	0.01
4	Brit J Ophthalmol	Q1	5.91	576	0.01
5	Jama-J Am Med Assoc	Q1	157.38	526	0.03
6	Med Image Anal	Q1	13.83	432	0.01
7	Diabetes Care	Q1	17.16	431	0.01
8	Plos One	Q2	3.75	413	0.02
9	Am J Ophthalmol	Q1	5.49	403	0.01
10	Lect Notes Comput Sc	未查到	—	391	0.03

序号	被引期刊	JCR分区	IF	被引频次	中介中心性
1	Ophthalmology	Q1	14.28	791	0.02
2	Invest Ophth Vis Sci	Q1	4.93	711	0.01
3	Ieee T Med Imaging	Q1	11.04	628	0.01
4	Brit J Ophthalmol	Q1	5.91	576	0.01
5	Jama-J Am Med Assoc	Q1	157.38	526	0.03
6	Med Image Anal	Q1	13.83	432	0.01
7	Diabetes Care	Q1	17.16	431	0.01
8	Plos One	Q2	3.75	413	0.02
9	Am J Ophthalmol	Q1	5.49	403	0.01
10	Lect Notes Comput Sc	未查到	—	391	0.03